POC Medical Systems, Inc.


POC Medical Systems Inc. (founded 2013) develops point-of-care diagnostic technologies based on a disposable microfluidic disk and an automated instrument for rapid, multiplexed blood-based screening. The company focuses on low-cost, portable screening workflows for settings with limited laboratory infrastructure and has pursued clinical validation, CE regulatory clearance for its platform application, mobile/cloud data integration, and distribution partnerships in emerging markets.

Industries

health-diagnostics
medical
medical-device

Nr. of Employees

small (1-50)

POC Medical Systems, Inc.

4659 Las Positas Rd., Livermore, CA 94551


Products

Microfluidic point-of-care testing platform (automated instrument and disposable disks)

Automated instrument that runs disposable centrifugal microfluidic disks to perform sample processing, reagent mixing, incubation and optical detection for rapid point-of-care assays.

Rapid blood-based multiplexed breast cancer screening workflow

A finger-prick blood immunoassay workflow that measures multiple cancer biomarkers on a disposable microfluidic disk with approximately 30-minute time-to-result and mobile/cloud result delivery.


Services

Conducting and coordinating clinical validation studies with local clinical partners and foundations to generate population-specific performance data.

Collaborative distribution arrangements with local partners for product introduction, public unveiling events, and deployment logistics in target emerging markets along with economic analyses to support adoption.

Secure cloud storage and mobile application workflows that allow clinicians to retrieve and review point-of-care screening results remotely.

Expertise Areas

  • Point-of-care diagnostics
  • Microfluidic cartridge platforms
  • Multiplexed immunoassays
  • Clinical validation and multi-center studies
  • Show More (6)

Key Technologies

  • Centrifugal microfluidics
  • Multiplexed immunoassays
  • Optical photometric detection
  • On-cartridge plasma separation
  • Show More (3)

News & Updates

Public unveiling of the rapid, portable breast cancer screening test in India with local officials and stakeholders present.

Announcement of a Series A funding round intended to support clinical beta testing and initial commercialization of the rapid breast cancer screening test.

The platform-based breast cancer screening application received CE certification for markets requiring EU conformity.

Recipient of a regional innovation award cited on company blog and press pages.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.